| Systematic (IUPAC) name | |
|---|---|
| (5aS,6R,8aS,9R,10S,12R,12aR)-10-ethoxy-3,6,9-trimethyldecahydro-3,12-epoxy[1,2]dioxepino[4,3-i]isochromene | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | not available |
| Legal status | ? |
| Routes | Intramuscular injection |
| Pharmacokinetic data | |
| Metabolism | Hepatic |
| Half-life | 20 hours |
| Identifiers | |
| CAS number | 75887-54-6 |
| ATC code | P01BE04 |
| PubChem | CID 72416 |
| ChemSpider | 16735673 |
| UNII | XGL7GFB9YI |
| ChEMBL | CHEMBL301267 |
| Chemical data | |
| Formula | C17H28O5 |
| Mol. mass | 312.401 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| (what is this?) (verify) |
|
Artemotil (INN; also known as β-arteether), is a fast acting blood schizonticide specifically indicated for the treatment of chloroquine-resistant Plasmodium falciparum malaria and cerebral malaria cases. It is a semi-synthetic derivative of artemisinin, a natural product of the Chinese plant Artemisia annua. It is currently only used as a second line drug in severe cases of malaria.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||